HK1210173A1 - Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators kcnq2/3 oh 6-- - Google Patents

Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators kcnq2/3 oh 6--

Info

Publication number
HK1210173A1
HK1210173A1 HK15111080.1A HK15111080A HK1210173A1 HK 1210173 A1 HK1210173 A1 HK 1210173A1 HK 15111080 A HK15111080 A HK 15111080A HK 1210173 A1 HK1210173 A1 HK 1210173A1
Authority
HK
Hong Kong
Prior art keywords
kcnq2
nicotinamides
modulators
amino
substituted
Prior art date
Application number
HK15111080.1A
Other languages
English (en)
Chinese (zh)
Inventor
Simon Lucas
Sven Khnert
Gregor Bahrenberg
Wolfgang Schrder
Achim Kless
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HK1210173A1 publication Critical patent/HK1210173A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15111080.1A 2012-04-18 2015-11-10 Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators kcnq2/3 oh 6-- HK1210173A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12002709 2012-04-18
PCT/EP2013/001134 WO2013156154A1 (en) 2012-04-18 2013-04-17 Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators

Publications (1)

Publication Number Publication Date
HK1210173A1 true HK1210173A1 (en) 2016-04-15

Family

ID=48227140

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111080.1A HK1210173A1 (en) 2012-04-18 2015-11-10 Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators kcnq2/3 oh 6--

Country Status (21)

Country Link
EP (1) EP2888233B1 (da)
JP (1) JP6033403B2 (da)
CN (1) CN104428287A (da)
AR (1) AR090739A1 (da)
AU (1) AU2013248637A1 (da)
BR (1) BR112014025840A2 (da)
CA (1) CA2870573A1 (da)
CY (1) CY1118255T1 (da)
DK (1) DK2888233T3 (da)
EA (1) EA201401142A1 (da)
ES (1) ES2605947T3 (da)
HK (1) HK1210173A1 (da)
HR (1) HRP20161424T1 (da)
HU (1) HUE030859T2 (da)
IL (1) IL235030A0 (da)
LT (1) LT2888233T (da)
MX (1) MX2014012494A (da)
PT (1) PT2888233T (da)
RS (1) RS55466B1 (da)
SI (1) SI2888233T1 (da)
WO (1) WO2013156154A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109071441A (zh) * 2016-04-22 2018-12-21 小野药品工业株式会社 Kcnq2-5通道活化剂的晶体多晶型
JP7262468B2 (ja) * 2017-12-29 2023-04-21 スリーエム イノベイティブ プロパティズ カンパニー 熱硬化性２剤型加工用接着剤組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2230392A1 (de) 1972-06-22 1974-01-31 Cassella Farbwerke Mainkur Ag Substituierte pyridinverbindungen und verfahren zu ihrer herstellung
DE2513949A1 (de) 1975-03-29 1976-10-07 Bayer Ag Azofarbstoffe
EP1361879A1 (en) * 2001-02-20 2003-11-19 Bristol-Myers Squibb Company 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
US6855829B2 (en) 2001-02-20 2005-02-15 Bristol-Myers Squibb Company 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease
EP2086935A1 (de) * 2006-10-16 2009-08-12 Grünenthal GmbH Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren
DE102006049452A1 (de) 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
DK2350093T3 (da) 2008-10-24 2012-11-12 Gruenenthal Gmbh Substituerede 4,5,6,7-tetrahydrothienopyridiner som KCNQ2/3-modulatorer til behandling af smerte, epilepsi og urininkontinens.
TWI475020B (zh) * 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
EP3318556A1 (en) * 2010-10-20 2018-05-09 Grünenthal GmbH Substituted 6-amino-nicotinamides as kcnq2/3 modulators

Also Published As

Publication number Publication date
HUE030859T2 (en) 2017-06-28
JP6033403B2 (ja) 2016-11-30
CY1118255T1 (el) 2017-06-28
ES2605947T3 (es) 2017-03-17
SI2888233T1 (sl) 2016-12-30
AU2013248637A1 (en) 2014-12-04
WO2013156154A1 (en) 2013-10-24
EP2888233A1 (en) 2015-07-01
CA2870573A1 (en) 2013-10-24
EP2888233B1 (en) 2016-09-28
HRP20161424T1 (hr) 2016-12-16
CN104428287A (zh) 2015-03-18
LT2888233T (lt) 2017-01-10
DK2888233T3 (da) 2017-01-09
MX2014012494A (es) 2015-01-15
IL235030A0 (en) 2014-12-31
PT2888233T (pt) 2017-01-04
RS55466B1 (sr) 2017-04-28
JP2015514728A (ja) 2015-05-21
AR090739A1 (es) 2014-12-03
EA201401142A1 (ru) 2015-03-31
BR112014025840A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
IL225762A0 (en) 6- amino-nicotinamides are converted as 2/3 kcnq modulators
EP2919672A4 (en) Autografting osteotome
PL2669546T3 (pl) Układ smarowania łożysk
EP2896842A4 (en) MAGNETIC BEARING
EP2749630B8 (en) Lubricant Composition
EP2841783A4 (en) BEARING ARRANGEMENT
EP2711573B8 (en) Bearing device
EP2863080A4 (en) BEARING HALF SHELL
HK1185347A1 (en) Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators kcnq2/3 2---3-
EP2906844A4 (en) BEARING ARRANGEMENT
EP2806179A4 (en) ROLLENLAGER
HK1209699A1 (en) Bearing protection system
GB2500487B (en) Tribological coating
EP2815141A4 (en) BEARING COMPONENT
GB201220163D0 (en) Sliding bearing
HK1203096A1 (en) Video ticket office
HK1185346A1 (en) Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators kcnq2/3 2-- 2---3-
GB2498460B (en) Bearing retainer
PL2706246T3 (pl) Łożysko zazębiające się
EP2932109A4 (en) BEARING HOUSING
GB201223351D0 (en) Sliding bearing
GB201223322D0 (en) Sliding bearing
HK1210173A1 (en) Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators kcnq2/3 oh 6--
GB201201498D0 (en) Bearing assembly
GB201112650D0 (en) Bearing preset system